Quarter Financials
Alzamend Neuro, Inc. (ALZN)
$1.42
+0.01 (+0.71%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2020 Q4
|
|---|
| Net Income | -3 | -4 | -3 | -4 | -2 | -1 | -1 | - |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -32 | -29 | -25 | -23 | -19 | -17 | -16 | -12 |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2020 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | 0 | 0 | - | - | - | - | - | - |
|---|
|
Year
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | 5 | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|